1
1. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71, 209–249 (2021).
2
2. Santos, A. C. D. S., Silva, N. N. T., Carneiro, C. M., Coura-Vital, W. & Lima, A. A. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians. BMC Public Health 20, 1–11 (2020).
3
3. WHO. Strategic framework for the comprehensive control of cancer cervix in South-East Asia Region. MMWR. Morbidity and Mortality Weekly Report vol. 64 (2015).
4
4. Wnukowski-Mtonga, P. et al. Scientific evidence supporting recommendations on the use of the 9-valent HPV vaccine in a 2-dose vaccine schedule in Australia. Commun Dis Intell (2018) 44, (2020).
6
6. Kementerian Kesehatan Indonesia. Keputusan Menteri Kesehatan Republik Indonesia nomor hk.01.07/menkes/6779/2021 tentang Program Introduksi Imunisasi HPV. 1–5 (2021).
7
7. World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. (World Health Organization, 2020).
8
8. Setiawan, D. et al. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis. PLoS One 15, (2020).
9
9. Sinshaw, M. T., Berhe, S. & Ayele, S. G. Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia. Infect Drug Resist 15, 781–793 (2022).
10
10. Suzuki, T. et al. HPV vaccine intention among university students during suspension of active recommendation in Japan. Hum Vaccin Immunother 18, (2022).
11
11. Lismidiati, W. et al. Feasibility of HPV vaccination program implementation: A qualitative study. Journal of Community Empowerment for Health 5, 47 (2022).
12
12. López-Maestro, M. et al. Quality of attachment in infants less than 1500 g or less than 32 weeks. Related factors. Early Hum Dev 104, 1–6 (2017).
13
13. Marzo, R. R. et al. Digital health literacy for COVID-vaccination and intention to be immunized: A cross-sectional multi-country study among the general adult population. Front Public Health 10, 1–10 (2022).
14
14. Alene, T., Atnafu, A., Mekonnen, Z. A. & Minyihun, A. Acceptance of human papillomavirus vaccination and associated factors among parents of daughters in gondar town, northwest Ethiopia. Cancer Manag Res 12, 8519–8526 (2020).
15
15. Larebo, Y. M. et al. Awareness, Acceptance, and Associated Factors of Human Papillomavirus Vaccine among Parents of Daughters in Hadiya Zone, Southern Ethiopia: A Cross-Sectional Study. Vaccines (Basel) 10, 1–15 (2022).
16
16. Winarto, H. et al. Knowledge, attitudes, and practices among Indonesian urban communities regarding HPV infection, cervical cancer, and HPV vaccination. PLoS One 17, 1–29 (2022).
17
17. Ota, Y. et al. Influence of LINE-Assisted Provision of Information about Human Papillomavirus and Cervical Cancer Prevention on HPV Vaccine Intention: A Randomized Controlled Trial. Vaccines (Basel) 10, 1–16 (2022).
18
18. Grandahl, M. et al. Parents’ knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PLoS One 13, 1–17 (2018).
19
19. Naoum, P., Athanasakis, K., Zavras, D., Kyriopoulos, J. & Pavi, E. Knowledge, Perceptions and Attitudes Toward HPV Vaccination: A Survey on Parents of Girls Aged 11–18 Years Old in Greece. Front Glob Womens Health 3, 1–8 (2022).
20
20. Balogun, F. M. & Omotade, O. O. Parental intention to vaccinate adolescents with HPV vaccine in selected communities in Ibadan, Southwest Nigeria: an application of Integrated Behavioral Model. Hum Vaccin Immunother 18, (2022).
21
21. Zhou, M., Qu, S., Zhao, L., Campy, K. S. & Wang, S. Parental perceptions of human papillomavirus vaccination in central China: the moderating role of socioeconomic factors. Hum Vaccin Immunother 15, 1688–1696 (2019).
22
22. Nguyen, L. H., Le, T. B. T., Le, N. Q. N. & Tran, N. T. T. Acceptance and Willingness to Pay for Vaccine Against Human Papilloma Virus (HPV) Among Parents of Boys in Central Vietnam. Front Public Health 10, 1–8 (2022).
23
23. Shaikh, M. Y. et al. Knowledge, Attitude, and Barriers Towards Human Papillomavirus (HPV) Vaccination Among Youths of Karachi, Pakistan. Cureus 11, (2019).
24
24. Dereje, N. et al. Knowledge and acceptance of HPV vaccination and its associated factors among parents of daughters in Addis Ababa, Ethiopia: a community-based cross-sectional study. Infect Agent Cancer 16, 1–7 (2021).
25
25. Zychlinsky Scharff, A. et al. Students’ age and parental level of education influence COVID-19 vaccination hesitancy. Eur J Pediatr 181, 1757–1762 (2022).
26
26. Alkalash, S. H. et al. Parents’ Knowledge of and Attitude Toward the Human Papillomavirus Vaccine in the Western Region of Saudi Arabia. Cureus 14, (2022).
27
27. Hendaus, M. A. et al. Parents attitudes toward the human papilloma virus (HPV) vaccine; A new concept in the State of Qatar. J Family Med Prim Care 10, 2488–2493 (2021).
28
28. Wen Lau, J. F., Woon, Y. L., Leong, C. T. & Teh, H. S. Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey. Osong Public Health Res Perspect 12, 361–373 (2021).
29
29. Marzo, R. R. et al. Factors influencing parents’ hesitancy to vaccinate their children aged 5-11 years old against COVID-19: results from a cross-sectional study in Malaysia. Front Public Health 11, 1091015 (2023).
30
30. Tobaiqy, Mansour., Mehdar, S., Altayeb, T. I., Saad, T. M. & Alqutub, S. T. Parental knowledge, views, and perceptions of human papilloma virus infection and vaccination-cross-sectional descriptive study. J Family Med Prim Care 12, 556–560 (2023).
31
31. Zheng, H., Jiang, S. & Wu, Q. Factors influencing COVID-19 vaccination intention: The roles of vaccine knowledge, vaccine risk perception, and doctor-patient communication. Patient Educ Couns 105, 277–283 (2022).
32
32. Sinshaw, M. T., Berhe, S. & Ayele, S. G. Knowledge and Attitude Towards Human Papillomavirus Vaccine and Associated Factors Among Mothers Who Have Eligible Daughters in Debre Markos Town, Northwest Ethiopia. Infect Drug Resist 15, 781–793 (2022).
33
33. Biyazin, T., Yetwale, A. & Fenta, B. Willingness to accept human papillomavirus vaccination in Jimma town, Ethiopia. Hum Vaccin Immunother 18, (2022).
34
34. Sitaresmi, M. N., Rozanti, N. M., Simangunsong, L. B. & Wahab, A. Improvement of Parent’s awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention. BMC Public Health 20, 1–9 (2020).
35
35. Fournet, N. et al. Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; Two systematic reviews. BMC Public Health 18, 1–17 (2018).
36
36. Fallucca, A. et al. Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy. Vaccines (Basel) 10, (2022).
37
37. Desfiani, Y. R., Sutawardana, J. H. & Widayati, N. Health literacy and post-vaccination covid-19 prevention behavior in the community: a cross-sectional study in Indonesia. Jurnal Ners 18, 64–70 (2023).
38
38. Lorini, C. et al. Health literacy and vaccination: A systematic review. Hum Vaccin Immunother 14, 478–488 (2018).
39
39. De Buhr, E. & Tannen, A. Parental health literacy and health knowledge, behaviours and outcomes in children: A cross-sectional survey. BMC Public Health 20, 1–9 (2020).
40
40. Bhoopathi, V., Bhagavatula, P. & Singh, M. Health literacy and its association with human papilloma virus vaccination among adults: Findings from the behavioral risk factor surveillance system. Hum Vaccin Immunother 18, (2022).
41
41. Samaria, D. et al. Edukasi Kesehatan Vaksinasi Human Papilloma Virus untuk Mencegah Kanker Serviks pada Siswi di Jakarta Timur. Jurnal Kreativitas Pengabdian Kepada Masyarakat (PKM) 6, 2916–2930 (2023).
42
42. 42. Tuharea M, Asmin E, Rahawarin H. Pengetahuan, Sikap dan Dukungan Sosial Berkaitan dengan Keikutsertaan Masyarakat pada Program Vaksinasi COVID-19 di Tulehu, Maluku Tengah. J Kesehat Komunitas. 9, 549–56, (2023).
